Elucidation of the regulatory mechanisms of YB-1 expression and the relevance of its nuclear localization in HCC may improve our understanding of HCC tumorigenesis and progression and provide a novel therapeutic target in HCC. The gene discussed is YBX1; the disease is hepatocellular carcinoma.